NOVADAQ SPY-PHI Drape, 7" x 104" (18 cm x 265 cm), Ref. HH 2020 (box of 20 HH2000 drapes), Steril...
FDA Device Recall #Z-3236-2017 — Class II — June 27, 2017
Recall Summary
| Recall Number | Z-3236-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 27, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | NOVADAQ TECHNOLOGIES INC. |
| Location | Burnaby, N/A |
| Product Type | Devices |
| Quantity | 3/20-drape boxes |
Product Description
NOVADAQ SPY-PHI Drape, 7" x 104" (18 cm x 265 cm), Ref. HH 2020 (box of 20 HH2000 drapes), Sterile, Rx.. Manufactured for: Novadaq Technologies Inc., Burnaby, BC, Canada. The SPY-PHI Drape is intended to cover the SPY-PHI System to maintain a sterile field, and as an aid in the clean-up of equipment after surgery or other medical procedures. The product is not intended to be used as patient drapes and they have no patient contact.
Reason for Recall
The sterile drape material may contain a pinhole compromising its integrity resulting in a breach of the sterile barrier.
Distribution Pattern
Worldwide Distribution. US (nationwide) to states of: CA, CO, ID, IL, NY, OR, and VA; and countries of: Canada, Belgium, and Lithuania.
Lot / Code Information
Lots #1703291, #1704141, and #1704101
Other Recalls from NOVADAQ TECHNOLOGIES INC.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-3234-2017 | Class II | NOVADAQ SPY-PHI Drape, 7" x 104" (18 cm x 265 c... | Jun 27, 2017 |
| Z-3235-2017 | Class II | NOVADAQ SPY-PHI PAQ Intended for use with the S... | Jun 27, 2017 |
| Z-2767-2016 | Class II | Sterile Drape, SK6000 PAQ drape pouch (for use ... | Aug 18, 2016 |
| Z-1032-2016 | Class II | PINPOINT Endoscopic Fluorescence Imaging System | Jan 29, 2016 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.